EMEA-001313-PIP01-12-M12

Table of contents

Key facts

Invented name
Zavicefta
Active substance
  • Ceftazidime
  • Avibactam
Therapeutic area
Infectious diseases
Decision number
P/0258/2022
PIP number
EMEA-001313-PIP01-12-M12
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
  • Treatment of infections due to aerobic Gram-negative bacteria
  • Treatment of intra-abdominal infections
  • Treatment of pneumonia
  • Treatment of urinary tract infections
Route(s) of administration
Intravenous use
Contact for public enquiries
Pfizer Europe MA EEIG

Tel. +44 (0)1304 646 607
E-mail: pip_enquiries@pfizer.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating